Are ther new medications forms on the horizon?

Several: Now that we have studies showing that long-term benefits for interferons and Copaxone are likely minimal at best, and that 60% of pts do not do well by 2 yrs, we are starting to see the emergence of far more potent meds. Gilenya and tysabri (natalizumab) are here. Tecfedera is close, lemtrada by end of year. Daclizumab, ocrelizumab, the newer s-1-p drugs being looked at. Even new drug for spasticity.